Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Daniel B. Sims; Gregg Rosner; Nir Uriel; José González-Costello; Frederick A. Ehlert; Ulrich P. Jorde

doi:10.1111/j.1540-8159.2011.03159.x

Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Daniel B. Sims, Gregg Rosner, Nir Uriel, José González-Costello, Frederick A. Ehlert, Ulrich P. Jorde

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

Original language	English (US)
Pages (from-to)	e144-e148
Journal	PACE - Pacing and Clinical Electrophysiology
Volume	35
Issue number	5
DOIs	https://doi.org/10.1111/j.1540-8159.2011.03159.x
State	Published - May 2012
Externally published	Yes

Keywords

chronic heart failure
left ventricular assist device
ventricular fibrillation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1111/j.1540-8159.2011.03159.x

Cite this

@article{17f93d8d267b468c82fa1dc4bd42cd98,

title = "Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device",

abstract = "Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)",

keywords = "chronic heart failure, left ventricular assist device, ventricular fibrillation",

author = "Sims, {Daniel B.} and Gregg Rosner and Nir Uriel and Jos{\'e} Gonz{\'a}lez-Costello and Ehlert, {Frederick A.} and Jorde, {Ulrich P.}",

year = "2012",

month = may,

doi = "10.1111/j.1540-8159.2011.03159.x",

language = "English (US)",

volume = "35",

pages = "e144--e148",

journal = "PACE - Pacing and Clinical Electrophysiology",

issn = "0147-8389",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

AU - Sims, Daniel B.

AU - Rosner, Gregg

AU - Uriel, Nir

AU - González-Costello, José

AU - Ehlert, Frederick A.

AU - Jorde, Ulrich P.

PY - 2012/5

Y1 - 2012/5

N2 - Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

AB - Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

KW - chronic heart failure

KW - left ventricular assist device

KW - ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84860835093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860835093&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2011.03159.x

DO - 10.1111/j.1540-8159.2011.03159.x

M3 - Article

C2 - 21679198

AN - SCOPUS:84860835093

SN - 0147-8389

VL - 35

SP - e144-e148

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

IS - 5

ER -

Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this